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Abstract 
N Lguanyl - 1,7-diaminoheptane (GC 7) is a potent inhibitor of deoxyhypusine synthase (DHS), the enzyme that catalyzes the first step 
in the hypusination of eukaryotic translation initiation factor 5A (elF-5A). Since elF-5A is the only known cellular substrate for DHS and 
GC 7 has been reported to block the proliferation of CHO cells, it has been suggested that DHS may be a novel target for anti-cancer 
therapy. In the present study we investigated the antiprotiferative effect of GC 7 on several tumorigenic ell lines under various growth 
conditions. We found that this compound inhibits the proliferation of H9 cells in suspension culture and the growth of HeLa cells and 
v-src-transformed NIH3T3 cells under both anchorage-dependent andanchorage-independent co ditions. Moreover, studies with NIH3T3 
cells and v-src-transformed NIH3T3 cells show that GC 7 inhibits the growth of both cell lines in monolayer culture with similar potency 
and could not reverse the transformed phenotype. In addition, the v-src-transformed cells grown under both anchorage-dependent a d
anchorage-independent co dilions howed similar sensitivity toward GC 7. These data indicate that GC 7 acts as a general antiproliferative 
agent and does not appear to preferentially target umorigenic ell types. Cell cycle analysis show that GC 7 reduces the CHO-K1 cell 
population in the Gl-phase of the cell cycle by 42% and increases the number of cells in the S-phase by 44%. This cell cycle distribution 
profile strikingly resembles the distribution of cells treated with puromycin. This result supports the hypothesis that the synthesis of a 
subset of proteins important for the S-phase progression of CHO-KI cells might be dependent upon hypusinated elF-5A. Thus the 
antiproliferative effect of GC 7 appears to be related to its interference with the progression of cell cycle, which also provides a possible 
explanation for the lack of selectivity of GC 7 between ontransformed and transformed cell types tested in this study. 
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1. Introduction 
Deoxyhypusine synthase (DHS) is the first enzyme 
involved in the hypusination of the eukaryotic translation 
initiation factor 5A (elF-5A) [1,2]. It catalyzes the transfer 
of the 4-aminobutyl moiety of spermidine to the e-amino 
Abbreviations: elF-5A, eukaryotic translation initiation factor 5A; 
GC 7, NLguanyl-l,7-diaminoheptane; DHS, deoxyhypusine synthase; 
DFMO, a-difluoromethylornithine; ODC, ornithine decarboxylase; CHX, 
cycloheximide; AG, aminoguanidine; Z-, carbobenzoxy-; Y', slope value 
derived from cell growth curve analyzed by linear regression. 
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group of lysine residue 50 in human elF-5A [3]. The 
deoxyhypusine r sidue which is formed is then hydroxyl- 
ated by a second enzyme, deoxyhypusine hydroxylase, to 
produce hypusinated elF-5A [1,2]. Recently, a series of 
synthetic inhibitors of DHS have been identified [4,5]. 
NLguanyl-l,7-diaminoheptane (GC7), which is the most 
potent among them, competitively inhibits the binding of 
spermidine and has a K i value of 10 nM [4]. Inhibition of 
[3H]spermidine incorporation into elF-5A by this com- 
pound has also been observed in CHO cells [4,5]. More- 
over, GC 7 has been shown to inhibit CHO cell prolifera- 
tion in culture [5]. 
elF-5A is the only known protein in eukaryotic ells 
that undergoes hypusination, and hypusination of elF-5A 
has been shown to be essential for the growth of some 
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tumorigenic ell lines [1,2]. These observations raise the 
possibility that DHS may be a potential anti-cancer target. 
We have selected GC 7 to test this hypothesis. Among the 
known inhibitors of the two enzymes involved in the 
hypusination of elF-5A, GC 7 is both the most potent and 
the most specific [4,5]. Although GC 7 itself is a polyamine 
analog, it does not significantly affect endogenous 
polyamine content in CHO cells [5]. It has been shown that 
the effect of GC 7 is dependent on its uptake by CHO cells 
and the intact compound is relatively stable within cells 
[5]. GC 7 inhibits CHO cell proliferation in a concentra- 
tion-dependent manner and there is a correlation between 
inhibition of hypusine synthesis and cell growth [5]. It has 
also been reported that GC 7 did not have a significant 
early effect on DNA synthesis [5]. Therefore, in the pre- 
sent study we used this compound to investigate whether 
inhibiting DHS would selectively block the growth of 
tumorigenic ells. 
2. Materials and methods 
2.1. Synthesis of  N CGuanyl-1, 7-diaminoheptane 
GC 7 was synthesized as described by Jakus et al. [4] 
except hat the guanylation was carried out with 1H-pyra- 
zole-l-carboxamidine. Briefly, mono-Z-l,7 diaminohep- 
tane. HBr (2.6 g, 7.5 mmot) was dissolved in 40 ml of 
DMF in the presence of 1.5 g of 1H-pyrazole-l-carbo- 
xamidine monohydrochloride (Fluka) and 4.5 g of N,N ~ 
Diisopropyl ethylamine. The reaction mixture was warmed 
to 550C and after 2 h, the DMF was removed in vacuo and 
the residue applied to a C-18 HPLC column. A gradient of 
acetonitrile (0-100%) in 0.1% TFA over 90 min at flow 
rate equal to 75 ml/min was used to isolate l-guanyl, 
7-N-Z-heptane. CF3COOH which was eluted at 35 min. 
Following lyophilization, 2.1 g were obtained. 
All chemical intermediates were confirmed by NMR. 
The theoretical mass of the compound was 173.176622, 
and the observed mass was 173.176010. The synthesized 
compound has the same K i value as reported, when 
assayed in vitro using the partially purified deoxyhypusine 
synthase from rat testis [3]. 
2.2. Cell lines and cell culture 
H9 cells, obtained from American Type Culture Collec- 
tion, were provided by Dr. A. Conley (Department of 
Virus and Cell Biology, Merck Research Laboratories, 
West Point, PA). Both NIH3T3 cells and v-src transformed 
NIH3T3 cells were kindly provided by Dr. N. Kohl (De- 
partment of Cancer Research, Merck Research Laborato- 
ries, West Point, PA). HeLa cells and CHO-K1 cells were 
purchased from American Type Culture Collection. Cells 
were maintained in 90% DMEM (NIH3T3 and v-src trans- 
formed NIH3T3), or 90% MEM (HeLa) or 90% RPMI 1640 
(H9) supplemented with 10% fetal bovine serum (Hy- 
Clone) or heat-inactivated fetal bovine serum (H9 cells). 
DMEM, MEM and RPMI 1640 were purchased from Gibco 
and all media were supplemented with 2 mM glutamine 
(Gibco) and an antibiotic mixture (Gibco) containing 100 
~g/ml  penicillin and 100 /zg/ml streptomycin. Cultures 
were kept at 37°C in a humidified atmosphere of 5% CO 2 
in air. Monolayer cells were split once a week and media 
were changed twice weekly. H9 cells were maintained in 
suspension at 10 5 - 10 6 cells per ml. Cells were collected 
either by trypsinizing the monolayer cells or withdrawing 
an aliquot of suspension cells. Cell numbers were deter- 
mined using a Coulter counter. 
To compare the rates of cell growth under different 
conditions, growth curves were analyzed by linear regres- 
sion and the slopes (E) of these lines were calculated. 
Aminoguanidine, an inhibitor of serum diamine oxi- 
dases [6], was added with GC 7 in all experiments de- 
scribed in this study to prevent he degradation of GC 7. 
Aminoguanidine alone up to 1 mM did not have any effect 
on the growth rate or on the viability of the cell lines 
described in this paper. Thus, for clarity in some figures, 
only the growth curve of aminoguanidine-treated c lls is 
shown as the control and the one with untreated cells has 
been omitted. 
To determine the cell viability of the monolayer cul- 
tured cells, both the floating cells in the culture media and 
the cells removed from the culture dish by trypsin-treat- 
ment were mixed. H9 cells in suspension were collected by 
centrifugation of the culture. Cell viability was measured 
by trypan blue staining. 
2.3. [ 3H]Spermidine incorporation into elF-5A 
Exponentially growing cells were incubated with 5-10 
/zCi/ml [3H]spermidine (Amersham) in the presence of 1 
mM aminoguanidine with or without various amount of 
GC 7 for 18 h at 37°C in a humidified atmosphere of 5% 
CO e in air. Cells were harvested by scraping into ice cold 
phosphate-buffered saline (PBS) containing 1 mM EDTA 
and collected by centrifugation at 4°C for 5 min at 600 
× g. The cells were resuspended in PBS and disrupted by 
the addition of an equal volume of cold 20% trichloro- 
acetic acid (TCA). The TCA-insoluble material was col- 
lected by centrifugation at3000 X g for 20 min and washed 
twice with 10% trichloroacetic acid. The precipitate was 
dissolved in a small volume of 0.25 M NaOH and the 
protein concentration was determined using the BCA assay 
(Pierce) with bovine serum albumin as a standard. To 
determine the [3H]spermidine uptake by cells, duplicate 
aliquots (10 /xl) from the soluble fraction of each sample 
were taken and counted in a Beckman scintillation counter. 
For the autoradiogram 100 /xg protein from each fraction 
was electrophoresed on 12% polyacrylamide slab gels in 
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the presence of SDS. To detect radiolabeled proteins, the 
gels were treated with ENTENSIFY (DuPont-New Eng- 
land Nuclear) according to the manufacturer's directions 
and dried under vacuum. Autoradiography was carried out 
for 1-2 weeks at -70°C using high-speed film (DuPont- 
New England Nuclear). 
2.4. Soft agar assays 
Soft agar assays were performed essentially as de- 
scribed [7]. Briefly, HeLa cells were seeded in a 0.3% top 
agarose layer in its culture medium over a bottom 0.6% 
agarose layer. Both layers contained the indicated concen- 
trations of GC 7 in the presence of 1 mM aminoguanidine. 
The cells were fed twice weekly with 0.5 ml medium with 
or without compound. Photomicrographs were taken 3 
weeks after seeding the ccdture. 
2.5. Cell cycle analysis 
The conditions for treating exponentially growing 
CHO-K1 cells with a variety of compounds known to 
affect the cell cycle are given in the appropriate figure or 
table legend. The cells were then trypsinized and collected 
by centrifugation for 5 min at 300 X g at room tempera- 
ture. The cells were further processed according to the 
instructions provided with the CycleTEST PLUS DNA 
Reagent Kit (Becton Dickinson). Briefly, cells were washed 
several times and treated with trypsin and RNAse. DNA 
was then stained with p~ropidium iodide. Samples were 
analyzed in a Becton Dickinson FACScan flow cytometer 
system equipped with a doublet discrimination module and 
two-parameter light-scatter detection. CellFIT software 
(Becton Dickinson) was used to collect and process the 
data. Twenty thousand events were usually collected for 
each sample. Statistical analysis was performed by SFIT, 
RFIT or SORB model systems in the CellFIT software. 
3. Results 
3.1. GC 7 inhibits both the anchorage-dependent a dthe 
anchorage-independent growth of transformed cell lines 
Previous studies have shown that GC 7 is cytostatic to 
CHO cells growing in monolayer culture [5]. To determine 
the cell type selectivity of this compound, two transformed 
cell lines were treated with GC 7 under several growth 
conditions. 
H9 cells, a human T-cell lymphoma line that grows in 
suspension culture, were treated with 1, 3 or 10 /zM GC 7. 
The growth curves of H9 cells, representative of 3 inde- 
pendent experiments, are shown in Fig. 1. GC 7 inhibited 
the growth of H9 cells in a concentration-dependent man- 
ner. While 1 /xM GC 7 had no significant effect on H9 cell 
proliferation, inhibition of growth became vident with 3 
/zM GC 7. At 10 /zM GC 7 H9 cell growth was completely 
blocked within 1 or 2 days after the addition of the drug. 
At day 5, when approx. 45% GC 7 remained in the medium, 
a slight increase in the number of cells was observed. 
Prolonged growth inhibition (up to two weeks) was 
achieved, however, when GC 7 was  replenished every four 
days (data not shown). The inhibition of H9 cell prolifera- 
tion by GC 7 was  reversible. Cells treated with 10 /zM 
GC 7 for 4 days resumed growth after removal of the 
compound and proliferated at a rate comparable to control 
cells (Fig. 1A). These results indicate that a cytostatic 
mechanism contributes to the antiproliferative effects of 
GC 7 upon H9 cells. The viability of cells treated with 10 
/xM GC 7 for one, two, three and four days, representative 
of 3 experiments, was 90%, 54 + 2%, 69 ___ 3% and 81 + 
1%, respectively, suggesting that the compound also has a 
cytotoxic effect on H9 cells. This is in contrast o results 
obtained using CHO cells whose growth was similarly 
inhibited by 10 /xM GC 7 but with approx. 90% viability 
(data not shown). 
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Fig. 1. Effect of GC 7 on the growth of H9 cells and HeLa cells. A: Exponentially growing H9 cells in suspension culture were treated either with 1 mM 
aminoguanidine alone (O) or in the presence of 1 #zM (O), 3 ~M (zx) or 10 /xM (• )  GC 7. Compounds were added at day 1, and an aliquot of cells was 
removed aily for cell number determination using a Coulter counter. At day 5, cells treated with 10 /xM GC 7 were centrifuged and resuspended in a 
GC7-free medium (R). The cell number was monitored for an additional 4 days. Values for the cell number epresent means + S.E.M. from at least three 
samples. B: HeLa cells exponentially growing in a monolayer culture were treated with 1 mM aminoguanidine alone (O), or in the presence of 10 /.LM 
(0) ,  30 /xM (zx), or 100 /xM (• )  GC 7. The cell number was determined daily. Values for the cell number epresent means + S.E.M. from 3 separate 
samples. 
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When monolayer-cultured HeLa cells were treated with 
10 /xM, 30 /xM or 100 p.M GCT, a dose-dependent effect 
on the growth rate of cells was observed (Fig. 1B). By 
comparing the slopes of the growth curves (E) (see Sec- 
tion 2), a quantitative measure of the effect of the drug on 
cell proliferation is obtained. GC 7 at 30 #M reduced the 
rate of growth by 20% (Y'. = 0.22 versus 0.27 for the 
untreated cells). The growth rate of cells treated with 100 
/xM GC 7 was decreased by 46% (E = 0.147). Thus, the 
time required for cell division was increased by 2-fold. 
The viability of cells treated with 30 /xM or 100 txM GC 7 
for one, two or three days was approx. 90%. 
The effect of GC 7 on colony formation by HeLa cells 
in soft agar plates was determined (Fig. 2). HeLa cells 
were seeded in soft agar containing GC 7 and colony 
formation was monitored for a three-week period. At 1 
/zM GC 7 no effect on the number and size of the colonies 
produced by HeLa cells in soft agar compared to the 
untreated cells was observed (Fig. 2A,B,C). When cells 
were treated with 10 /xM GCT, significantly fewer and 
smaller colonies were generated (Fig. 2D). In the presence 
of 30 /xM GC 7 there were no large colonies and mostly 
single cells were observed (Fig. 2E). 
3.2. GC 7 is not selective for  tumorigenic ells 
In the case of HeLa cells anchorage-independent cell 
growth appears to be more sensitive to GC 7 than anchor- 
age-dependent growth. It was, therefore, of interest to 
determine if this difference was seen in other transformed 
cell types and whether cells possessing the transformed 
phenotype are more sensitive to GC 7 than their nontrans- 
formed counterparts. To address these points, we tested the 
effect of GC 7 on a parental NIH3T3 cell line and its 
counterpart transformed by the v-src oncogene. 
NIH3T3 cells display contact-inhibition when grown to 
high density and cannot grow in soft agar. In contrast, the 
v-src-transformed counterpart grows without contact inhi- 
bition and is anchorage-independent. In monolayer culture, 
both cell lines grew at a comparable rate (Fig. 3). When 
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Fig. 2. Effect of GC 7 on anchorage-independent growth of HeLa cells. HeLa cells (104) were seeded into either egular soft agar culture (A), or cultures 
containing 1mM aminoguanidine with or without GC 7 (B-E). (B), no GC 7 added; (C) 1 /xM GCT; (D), 10 /xM GC 7 and (E) 30/xM GC 7. Cells were 
fed twice weekly with 0.5 ml medium without compound. Photographs were taken 3 weeks after seeding the culture and are representative of triplicate 
samples in two experiments• Similar results were seen when the compound was replenished every 3-4 days after the initial seeding (data not shown). 
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Fig. 3. Effect of GC 7 on the growth of NIH3T3 cells and v-src-trans- 
formed NIH3T3 cells. NIH3T3 cells (A) and v-src-transformed NIH3T3 
cells (B) were treated with 1 mM aminoguanidine alone (O), or in the 
presence of 10 /xM (O) or 100 /xM (11) GC 7. The ceil number was 
determined aily and is presented on a logarithmic scale. Values for the 
cell number epresent means + S.E.M. from 3 separate samples. 
these cells were treated with 10 /zM GCT, there was no 
effect on the growth rate of either cell line (Fig. 3). 
Increasing the concentration of GC 7 to 100 /zM inhibited 
the growth of NIH3T3 cells by 60% (E = 0.138 5- 0.008 
versus 0.347 + 0.012 for the untreated cells) (Fig. 3A) and 
the growth of v-src-transformed NIH3T3 cells by 63% 
(• = 0.146 5- 0.014 versus 0.39 + 0.014 for the untreated 
cells) (Fig. 3B). The extent of the inhibition was indistin- 
guishable (P  = 0.6366). In addition, GC 7 was  not able to 
reverse the cell morphological changes associated with 
v-src-transformation (data not shown). Similarly, the mor- 
phology of NIH3T3 cells transformed by overexpressing 
ornithine decarboxylase was not altered by treatment with 
GC 7 (E. H61tt~i, personal communication). 
GC 7 also inhibited the anchorage-independent growth 
of v-src-transformed NIH3T3 cells in soft agar (Fig. 4). In 
accord with the concentration-dependent effect of GC7 in 
monolayer culture, 10 /xM GC 7 had no effect on the 
number and size of the colonies produced by v-src-trans- 
formed NIH3T3 cells in soft agar (Fig. 4D), while 100 
/xM GC 7 completely abolished the ability of these cells to 
grow on soft agar (Fig. 4E). 
Consistent with the effect of GC 7 on cell growth in 
both monolayer culture and soft agar and the known ability 
of GC 7 to inhibit DHS [4], the incorporation of 
Fig. 4. Effect of GC 7 on anchorage-independent growth of v-src- transformed NIH3T3 cells. V-src transformed NIH3T3 cells (104) were seeded into 
either egular soft agar culture (A), or cultures containing 1mM aminoguanidine with or without GC 7 (B-E). (B), no GC 7 added; (C) 1 /zM GC7; (D), l0 
/xM GC 7 and (E) 100 /zM GC 7. Cells were fed twice weekly with 0.5 ml medium without compound. Photographs were taken 3 weeks after seeding the 
culture and are representative of triplicate samples in two experiments. 
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Fig. 5. Effect of GC 7 on [3H]spermidine incorporation into elF-5A in 
NIH3T3 cells and v-src-transformed NIH3T3 cells. Cells were labelled 
with [3H]spermidine for 18 h in the presence and absence of GC 7 as 
described in Section 2. Shown is an autoradiograph of [3H]spermidine 
incorporation into elF-5A in NIH3T3 cells (lanes 1-3) and v-src-trans- 
formed NIH3T3 cells (lanes 4-6). All samples were labelled in the 
presence of 1 mM aminoguanidine. Lanes 1 and 4, no GC 7 added; lanes 
2 and 5, 10 /xM GCT; lanes 3 and 6, 100 /xM GC 7. 
[3H]spermidine into newly synthesized elF-5A was not 
appreciably affected by 10 /xM GC 7 but was completely 
abolished by 100 /xM GC 7 (Fig. 5). The specific activity 
of [3H]spermidine in NIH3T3 cells treated with 0, 10 /xM 
or 100/xM GC 7, expressed as cpm per microgram of total 
cell protein, was 68200, 72000 and 65500, respectively; in
v-src-transformed NIH3T3 cells, it was 70600, 67000 and 
62400, respectively. Thus, the inhibition of the hypusina- 
tion of elF-5A by GC 7 is not simply due to competition 
for the cellular uptake of spermidine by GC 7. 
3.3. GC 7 interferes with the progression of the cell cycle 
To further characterize the antiproliferative effect of 
GCT,  we analyzed the CHO cell cycle distribution profile 
in the presence of GC 7 and compared it to the profile of 
untreated cells as well as to those obtained from cells 
treated with several compounds whose effects on the CHO 
cell cycle are well known. These compounds included 
DFMO, a specific inhibitor of ornithine decarboxylase [8], 
mimosine, a metal chelator, also reported to inhibit deoxy- 
hypusine hydroxylase [9] and two protein synthesis in- 
hibitors, cycloheximide [10] and puromycin [11 ]. Exponen- 
tially growing CHO-KI cells were treated with these agents 
at the concentrations indicated in Table 1. Cells were 
harvested either one or three days after the treatment and 
processed as described in Section 2. To quantitate the 
percentage of cells in each phase of the cell cycle, propid- 
ium iodide-stained cell nuclei were analyzed in a FACScan 
flow cytometer. These results are summarized in Table 1 
and representative examples of the DNA histograms are 
shown in Fig. 6. GC 7 at a concentration of 10 #M 
reduced the cell population in Gl-phase by 42% and 
increased the number of cells in S-phase by 44% (Table 1 
and Fig. 6C, 6D). This concentration of GC 7 was  also 
required to inhibit CHO-K1 cell proliferation and 
[3 H]spermidine incorporation i to eIF-5A (data not shown). 
In contrast o the effect of GC7,  three of the reference 
compounds which were tested, DFMO (Table 1 and Fig. 
6E), mimosine (Table 1 and Fig. 6F) and cycloheximide 
(Table 1 and Fig. 6G) increased the number of cells in 
Gl-phase by 82%, 86% and 55%, respectively, and re- 
duced the cell population in S-phase by 77%, 73% and 
40%, respectively. In contrast, the DNA histogram of 
puromycin-treated cells, unlike that for cycloheximide- 
treated cells, showed areduced number of cells in Gl-phase 
(by 43%) and an increased cell population in S-phase (by 
33%). Thus, the DNA histogram profile of puromycin- 
Table 1 
Effect of GC 7 on CHO-K1 cell cycle distribution 
Cell distribution (%) 
GI S G2/M N ~ 
Untreated (3-d) 44_+2 
Amoniguanidine 
l mM(1-d) 46_+ 1 
Aminoguanidine 1 mM +GC 7 
10 NM(1-d) 30___2 
(3-d) 29-+1 
( -42%)  
DFMO 
1 mM (l-d) 
(3-d) 
Mimosine 
0.3 mM (l-d) 
(3-d) 
Cycloheximide 
10/xg/ml (l-d) 
(3-d) 
Puromycin 
10/xg/ml (l-d) 
(3-d) 
50_+2 
80_+ 1 
(+82%) 
71_+5 
82_+4 
( + 86%) 
69_+ 1 
68 
(+55%) 
25+3 
( -43%)  
b 
48+3 7+2 3 
45+2 8+1 3 
58+3 13+2 3 
62-t-2 10+ l 3 
( + 44%,) 
44+3 7___2 2 
11+1 9+1 2 
( -77%)  
19_+6 10+1 2 
13+1 6+2 2 
( -73%)  
26+2 6+ 1 3 
29+ 1 4+2 2 
( - 40%) 
64+2 13+4 3 
(+33%) 
2 
a, number of separate xperiments. 
b, no viable cells. 
Cells were treated with various agents for the indicated length of time. 
They were collected and processed as described in Section 2. Propidium 
iodide-stained nuclei were then analyzed in a FACScan flow cytometer to 
obtain a DNA histogram. The percentage of cells distributed in each 
phase of cell cycle was calculated from the DNA histogram using SFIT, 
RFIT or SORB model systems in the CellFIT software. Values in the 
table represent means_S.E.M, from at least 4 samples from 2 or 3 
independent experiments. The values in parenthesis ndicate the percent 
change in the fraction of cells in that phase of the cell cycle compared to 
the fraction of cells in the same phase of the cell cycle from the untreated 
samples, except hat the percent change in GC7-treated cells was calcu- 
lated using the value from aminoguanidine-treated cells as control. 
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Fig. 6. Effect of GC 7 on CHO-K1 cell cycle distribution. DNA histogram 
of exponentially growing CHO-K1 cells treated with different agents. (A) 
untreated ceils; (B) cells treated with 1 mM aminoguanidine (AG) alone 
for 3 days; (C) cells treated with 10/xM GC 7 for 1 day in the presence of 
1 mM aminoguanidine; (D) celh; treated with l0 k~M GC7 for 3 days in 
the presence of 1 mM aminoguanidine; (E) cells treated with 1 mM 
DFMO for 3 days; (F) cells treated with 300 /zM mimosine for 3 days; 
(G) cells treated with 10 ~g/ml  cycloheximide (CHX) for 3 days; and 
(H) cells treated with 10 /zg/ml puromycin for 1 day. Each of these 
DNA histograms i representative of at least 4 separate samples from 2-3 
independent experiments. 
treated cells closely resembled that observed for GC 7- 
t reated cells (Table 1 and Fig. 6H). 
4. Discussion 
Hypusination of elF-5A has been reported to be re- 
quired for the growth of eukaryotic ells [1,2,12,13] and 
inhibitors of DHS, the first enzyme involved in the hypusi- 
nation reaction, block the proliferation of CHO cells [4,5]. 
On this basis it was proposed that these inhibitors might 
have practical application as chemotherapeutic agents 
against umor cells [5]. The effects of GC 7 observed on the 
two human tumor cell lines, H9 and HeLa, in this study 
support his proposal. However, from our initial data it was 
unclear whether or not the growth of tumorigenic cell lines 
is more sensitive to the depletion of hypusinated elF-5A 
than normal cells, and, therefore, whether or not inhibiting 
DHS would selectively block the growth of tumorigenic 
cell lines. To address this question, we have investigated 
the effect of GC7, a potent inhibitor of DHS, on a non- 
transformed parental NIH3T3 cell line and its highly tu- 
morigenic ounterpart transformed by the v-src oncogene. 
GC 7 inhibited the growth of NIH3T3 and v-src-trans- 
formed NIH3T3 cell lines in monolayer culture with a 
similar potency. The dose-dependent i hibition of hypusi- 
nation of newly synthesized cellular elF-5A by GC 7 was 
also similar for both cell lines. Therefore, GC 7 has no 
selective growth inhibitory effect on v-src-transformed 
NIH3T3 cells in monolayer culture. In addition, GC 7 
failed to reverse the phenotypical changes mediated by 
v-src transformation. This lack of an effect does not appear 
to be specific to the mechanism of transformation by v-src, 
since NIH3T3 cells transformed by overexpressing or- 
nithine decarboxylase howed similar results. Moreover, 
the same concentration of GC 7 required to inhibit v-src- 
transformed NIH3T3 cells in monolayer culture was needed 
to block colony formation of these cells in soft agar plates. 
This further suggests that the anti-neoplastic property of 
GC 7 against tumorigenic ells growing on soft agar is 
likely due to its general antiproliferative effect. The differ- 
ence in the concentration of GC 7 needed to inhibit the 
growth of HeLa cells in monolayer culture versus on soft 
agar plates could result simply from the more stressful 
growth conditions in soft agar which could in turn increase 
the susceptibility of these cells to GCT, or more specifi- 
cally from a mechanism related to anchorage-independent 
growth which is unique to HeLa cells. Notwithstanding 
this particular esult, the data suggest hat the effect of 
GC 7, and perhaps other inhibitors of deoxyhypusine syn- 
thase, is primarily on cell proliferation, and not on cellular 
transformation. 
This antiproliferative property of deoxyhypusine syn- 
thase inhibitors is distinct from inhibitors of farnesyl-trans- 
ferase for example, which have been shown to rapidly 
reverse the Ras oncogene transformed phenotype without 
affecting eneral cell proliferation [7]. However, this prop- 
erty of GC 7 is similar to many anti-cancer agents currently 
in the clinic which have anti-neoplastic actions, such as 
antimetabolites, DNA-binding antibiotics, platinum analogs 
and alkylating agents. Whether the antiproliferative effect 
achieved through inhibiting deoxyhypusine synthase pro- 
vides additional advantages over the other approaches used 
in the clinic will require further investigation. 
The data from cell cycle analysis howed that CHO-K1 
cells treated with GC 7 accumulated in the S-phase of the 
cell cycle. This implies that there might be a subset of 
proteins whose synthesis is sensitive to the inhibition of 
DHS and is required for the progression of CHO cells 
through S-phase. Evidence for such a subset of proteins is 
provided by a recent study with mimosine that showed the 
existence of a subset of mRNAs whose association with 
polysomes was correlated with the degree of hypusination 
of eIF-5A [16]. Interestingly, the cell cycle distribution 
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profile of GCT-treated CHO-K1 cells closely resembles the 
one mediated by puromycin and is distinct from the pat- 
terns observed after treatment with DFMO, mimosine or 
cycloheximide. Although puromycin and cycloheximide 
are both protein synthesis inhibitors, they give rise to 
distinct cell cycle distribution profiles. This could be ex- 
plained by previously reported ifferential effects of these 
two compounds on the synthesis of specific subsets of 
proteins in cells [11,14,15]. The similarity between the cell 
cycle distribution profile generated by treatment with 
puromycin or GC 7 raises the possibility that the inhibition 
of the synthesis of a subset of proteins in the presence of 
GC 7 may overlap with the set of proteins whose synthesis 
is particularly sensitive to puromycin. 
Both DFMO and mimosine are compounds that inhibit 
hypusination of elF-5A [1,2]. The former exerts its effect 
by reducing the intracellular supply of spermidine [17]; the 
latter inhibits deoxyhypusine hydroxylase [9]. Blockades at 
either G I or S-phase of the cell cycle have been reported 
with DFMO treatment [8,18-21] and inhibition of the 
hydroxylation of other proteins by mimosine has also been 
shown [22]. Thus, it appears that each of these agents 
interferes with the synthesis or function of multiple pro- 
teins and the effect of either of these compounds on the 
cell cycle could be the net result of their inhibition of 
several cellular processes. In the case of DFMO and GCT, 
the difference in the effects on the CHO cell cycle between 
these compounds observed in this study may be at- 
tributable to targeting at a position further upstream in the 
biosynthetic pathway of polyamines by DFMO. This could 
easily result in a different spectrum of proteins affected by 
each drug. In general, attempting to analyze the cellular 
effects of drugs that alter the biosynthesis of hypusinated 
eIF-5A will be complex. The existence of multiple forms 
of eIF-5A, for example, hypusinated, eoxyhypusinated (in 
the presence of mimosine) and non-hypusinated (in the 
presence of GC 7 or DFMO), and their relative ability to 
modulate different cell function as well as their relative 
levels in cells may all be important factors. This could 
explain in part the difference in the effects on cell cycle 
seen between GC 7 and mimosine. 
In summary, our data suggest hat, by inhibiting hypusi- 
nation of eIF-5A, GC 7 may affect the synthesis of several 
proteins and, thus, these experiments provide an explana- 
tion for the lack of significant selectivity displayed by GC 7 
for the cell lines tested in this study. We recognize that it 
is also possible that some of the cellular effects of GC 7 
may not be related to its effect on the hypusination of 
eIF-5A. While the precise mechanism for the effect of 
GC 7 off the cell cycle remains to be elucidated, it is likely 
that interference with the progression of the cell cycle by 
GC 7 accounts  for its antiproliferative effect. 
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